Bing Quan
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Liver Disease Diagnosis and Treatment (5 papers)Ferroptosis and cancer prognosis (4 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- SHILAP Revista de lepidopterologíaCancer LettersClinica Chimica Acta
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bing Quan
19 papers receiving 296 citations
Peers
Comparison fields: 5 of 50
- Hepatology 158
- Epidemiology 106
- Oncology 98
- Molecular Biology 79
- Cancer Research 74
Countries citing papers authored by Bing Quan
This map shows the geographic impact of Bing Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Quan more than expected).
Fields of papers citing papers by Bing Quan
This network shows the impact of papers produced by Bing Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Quan. The network helps show where Bing Quan may publish in the future.
Co-authorship network of co-authors of Bing Quan
This figure shows the co-authorship network connecting the top 25 collaborators of Bing Quan. A scholar is included among the top collaborators of Bing Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Quan. Bing Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 10 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 4 | |
| 10 | LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. | 26 |
| 11 | 21 | |
| 12 | 4 | |
| 13 | 24 | |
| 14 | 5 | |
| 15 | 4 | |
| 16 | 23 | |
| 17 | 79 | |
| 18 | 35 | |
| 19 | 0 | |
| 20 | 40 |
About Bing Quan
Bing Quan is a scholar working on Hepatology, Oncology and Immunology, having authored 24 papers that have together received 300 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Hepatology (158 citations), Cancer Research (74 citations) and Oncology (98 citations). Bing Quan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Wenfeng Liu, Lei Liang, Tian Yang, Mengchao Wu, Ming-Da Wang, Han Wu, Timothy M. Pawlik, Feng Shen, Wan Yee Lau and Li‐Yang Sun. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Letters and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.